ArtiSential® for Rectal Cancer Surgery

Seoul National University

Status: Completed

Conditions: Rectal Cancer

Treatments: Device: ArtiSential®

Study type: Observational

Funder types: Other

Identifiers

NCT06236282

2208-0071346

Details and patient eligibility

About

This study aimed to assess efficacy of ArtiSential® in reducing laparoscopic rectal cancer surgery duration. We retrospectively reviewed the data of patients who underwent laparoscopic low or ultralow anterior resection for primary mid-to-low rectal cancer, performed by a single surgeon in 2012-2022. Patients were divided into groups, use group vs. non-use group, based on the use or non-use of the ArtiSential®. The total mesorectal excision quality and resection margin status did not differ between the groups. ArtiSential® reduced operative time without impairing surgical quality or oncologic outcomes.

Enrollment: 93 patients

Sex: All

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• mid-to-low rectal caner (witing 10cm of the anal verge)
• laparoscopic surgery

Exclusion criteria

• combined surgery
• recurrent rectal cancer surgery

Trial design

93 participants in 2 patient groups

ArtiSential® Use

Description:

Laparoscopic low anterior resection, with use of both straight devices and articulated devices

Treatment:

Device: ArtiSential®

ArtiSential® Non-Use

Description:

Laparoscopic low anterior resection, with use of straight devices only